Indoco Remedies Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indoco Remedies Quarterly Results    (INDOCO)

Here are the latest quarterly results of Indoco Remedies. For more details, see the Indoco Remedies financial fact sheet and Indoco Remedies share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Indoco Remedies Quarterly Results

No. of Mths
Qtr. Ending
3
Mar-18
3
Jun-18
3
Sep-18
3
Dec-18
3
Mar-19
3
Jun-19
3
Sep-19
3
Dec-19
8-Qtr Chart
Click to enlarge
Net Sales Rs m2,6962,1752,3562,6262,5202,5272,9202,893 
Other income Rs m1033649667 
Turnover Rs m2,7072,1782,3602,6312,5702,5332,9262,901 
Expenses Rs m2,2022,0602,2382,3782,2352,2992,5982,542 
Gross profit Rs m494116118248286228321351 
Depreciation Rs m163167177177195170180176 
Interest Rs m8372503746615469 
Profit before tax Rs m258-120-1053994393113 
Tax Rs m530-27-14-22-192020 
Profit after tax Rs m205-120-7853116227393 
Gross profit margin %18.35.35.09.411.39.011.012.1 
Effective tax rate %20.50.026.0-36.9-23.7-678.621.317.5 
Net profit margin %7.6-5.5-3.32.04.60.92.53.2 
Diluted EPS Rs 2.2 -1.3 -0.8 0.6 1.3 0.2 0.8 1.0  
Diluted EPS (TTM) Rs 4.5 5.5 2.5 0.7 -0.3 1.2 2.9 3.3  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Indoco Remedies 3QFY20 Result Performance Review

More Miscellaneous Company Quarterly Results:   AMAR REMEDIES  AJANTA PHARMA  SUN PHARMA  CIPLA  ALEMBIC LTD  

Compare INDOCO REMEDIES With:   AMAR REMEDIES  AJANTA PHARMA  SUN PHARMA  CIPLA  ALEMBIC LTD  

Compare INDOCO REMEDIES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 231 Points Higher; Capital Goods and FMCG Stocks Witness Buying(Closing)

Indian share markets continued their momentum during closing hours and ended their trading session on a positive note. At the closing bell, the BSE Sensex stood higher by 231 points (up 0.6%).

Views on news

INDOCO REMEDIES Announces Quarterly Results (3QFY20); Net Profit Up 74.9% (Quarterly Result Update)

Jan 27, 2020 | Updated on Jan 27, 2020

For the quarter ended December 2019, INDOCO REMEDIES has posted a net profit of Rs 93 m (up 74.9% YoY). Sales on the other hand came in at Rs 3 bn (up 10.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (2QFY20); Net Profit Up 194.1% (Quarterly Result Update)

Nov 5, 2019 | Updated on Nov 5, 2019

For the quarter ended September 2019, INDOCO REMEDIES has posted a net profit of Rs 73 m (up 194.1% YoY). Sales on the other hand came in at Rs 3 bn (up 23.9% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of INDOCO REMEDIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of INDOCO REMEDIES. Also includes updates on the valuation of INDOCO REMEDIES.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

How to Buy the Best Safe Stocks in 2020 (The 5 Minute Wrapup)

Jan 17, 2020

Don't fall for the safe stocks narrative going around in the stock market these days.

For 1,000%+ Gains, Follow the 8-Year Cycle in the Stock Market (Fast Profits Daily)

Jan 17, 2020

This is how the biggest trading profits are made.

The Best Asset Class to Invest in 2020 (Fast Profits Daily)

Jan 24, 2020

Why I'm most bullish on this asset class above all else in 2020.

Small is Beautiful in 2020 (A Prediction You Don't Want to Miss) (Profit Hunter)

Jan 17, 2020

As always Apurva will predict the best asset class to invest in in the coming year, last year he predicted gold and he was bang on! And this year he predicts... wait, you have to read to find out! Don't miss this.

The Smallcap Rebound Has Begun (13 Stocks Up Over 20% in the last Month) (Profit Hunter)

Jan 21, 2020

The best smallcap stocks to bet on to get rich in this market rebound.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

INDOCO REMEDIES SHARE PRICE


Jan 29, 2020 (Close)

TRACK INDOCO REMEDIES

  • Track your investment in INDOCO REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDOCO REMEDIES

INDOCO REMEDIES - CREST VENTURES COMPARISON

COMPARE INDOCO REMEDIES WITH

MARKET STATS